Best Practices for Private Placement Memorandums

By David Mosley, Director of Sales, ShareVault

Best Practices for Private Placement MemorandumsAs a former institutional salesman at an investment bank, I recognize the complexity and risks associated with preparing and distributing a Private Placement Memorandum (PPM). The Private Placement Memorandum is a stand-alone document, in that it contains all the information an investor needs to make an investment decision. As such, PPMs must be drafted very carefully to ensure that they are comprehensive and do not omit any information that a reasonable person would consider relevant in making an investment decision. It’s also crucial that they not contain any information that could be considered misleading.

Continue reading

5 Tips for Successful Biotech/Pharma Partnering

5 Tips for Successful Biotech/Pharma PartneringBy Stephen Joseph, VP of Market Development, ShareVault
Based on the white paper by Linda Pullan, PhD, Pullan Consulting

Download the White Paper: How to Win at the Partnering GameBiotech companies know that it is essential to align with strategic partners to advance their drug candidates to market. To partner successfully the small biotech company must effectively play the partnering game. The process requires determining when it’s best to seek out a partner, having a defined strategy, clearly communicating how your opportunity is unique, understanding the partnering process both from your perspective and the partner’s, and then reaching out to a variety of partners in order to find one that best fits your needs.

#1 Decide When to Play

Deciding when to seek out a partnership may be largely determined by what it is you want to accomplish. The goal of partnering is typically to obtain non-dilutive funding or to offload expenses when development costs, such as Phase III trials, become too burdensome. But a partnership can also be valuable for gaining a partner’s expertise and resources, or for the validation that partnership brings to your company. Also keep in mind that a partnership will generally increase the probability of that your drug will be approved.

Continue reading

ShareVault Reacts Quickly To Fix Two Security Threats: Poodle and MS14-058

no poodlesThis week was busy in terms of global security threats.  On Tuesday, Microsoft announced MS14-058, a critical security vulnerability in the kernel-mode driver that could allow remote code execution, and on the same day, Google announced its discovery of POODLE (Padding Oracle On Downloaded Legacy Encryption), a security bug in SSLv3, an encryption technology used in legacy computer systems, such as Microsoft XP Internet Explorer 6, prior to Service Pack 3.

ShareVault implemented the fix to MS14-058 on Wednesday, and a fix to POODLE was implemented on Thursday.

Some users running Windows XP with Internet Explorer 6 without service pack 3 will need to upgrade their browser in order to continue using ShareVault.  This represents less than a fraction of a percent of our users.  While we apologize for the inconvenience to these users, we believe that this was the right decision given the security threat posed by the POODLE vulnerability.

At ShareVault, security is a top priority, and our customers count on us to react quickly to security threats.  We are very proud that our security, operations and development teams reacted rapidly to these threats and implemented quick fixes.

no poodle

Are You Exit Ready? Six Areas of Your Company to Examine as if You Were a Buyer

Are You Exit Ready? Six Areas of Your Company to Examine as if You Were a BuyerBy John Badger, Co-Founder and VP of Marketing and Product, ShareVault
Based on the white paper by Andy Thorsen, “Preparing for Your Exit”

You’ve probably heard the saying that tech companies are generally bought, not sold. This means that you, as the seller, may have very little control over who acquires your company and, perhaps more importantly, when that acquisition takes place. Constant readiness then becomes imperative in order to both look attractive to potential buyers and to maximize the value of your company.

Download the White Paper: Preparing for Your Exit

Download the White Paper: Preparing for Your Exit

When an exit is not on your company’s radar, certain documentation can fall through the cracks or become dated, which will be a red flag should a buyer approach your company. And, if it’s a red flag for a buyer, then it should be a red flag for you as well. If a buyer wouldn’t want to inherit your company’s liabilities, why would you want to retain them? But if being prepared for an exit is part of your company’s DNA, not only will you avoid scrambling for data during due diligence, but you’ll have data in place to inform you of your company’s health, expose weaknesses and liabilities, grow your company and increase value.

Continue reading

Oil and Gas Industry M&A Deals Reach $141B in H1

Oil & Gas Industry Trends & ChallengesDeloitte’s mergers and acquisitions specialists just released a report on what’s driving activity in the oil and gas industry, which suggests the deal market may be poised for a rebound.

A total of 299 transactions were completed in the first six months of 2014, one less than in the same period a year earlier. At the same time, the total value of deals in the first half of 2014 rose by nearly $40 billion globally to $141 billion from $102 billion in the first half of 2013.

Download the Solution Brief: Oil & Gas Industry Trends & Challenges

Download the Solution Brief: Oil & Gas Industry Trends & Challenges

The United States and Canada accounted for 61 percent of all deal activity, though this percentage slipped slightly from the first half of 2013. In the first half of the year, both Asia and South America saw increases in their share of the deal count rising nearly 20 percent and 50 percent, respectively.

Continue reading

Upcoming Webinar: “Making Sense of New Patent Litigation Alternatives”

John ResekOctober 23, 2014, 11am-12pm PDT / 2-3pm EDT

In this webinar, John Resek, Ph.D., J.D. will compare and contrast the two new proceedings for patent litigation created by the America Invents Act, Inter Partes Review (IPR) and Post-Grant Review (PGR), to provide an understanding of how they affect patent owners as well as patent challengers.

He will answer questions such as:

  • How can a patent owner protect their patent estate?
  • What is the advantage to the patent challenger of a post grant proceeding?
  • What important strategic issues should be considered?

Throughout the webinar, feel free to submit your own questions, which Dr. Resek will address at the end if there is time.

Register today: http://bit.ly/patent-litigation

Register for the Webinar

3 Tips to Ensure Your M&A Growth Strategy is Successful

3 Tips to Ensure Your M&A Growth Strategy is Successful, Due Diligenceby Richard Andersen, CEO, ShareVault

Turn to the financial section of any newspaper today and you’ll likely see an article concerning M&A activity. After nearly a decade of austerity, companies across a wide spectrum of industries are seeking to grow their business, counter tepid business markets at home, add synergy, enter new markets, or diversify their product line by acquiring other companies.

Sample Due Diligence Checklist

Sample Due Diligence Checklist

Cisco embarked on a journey two decades ago that provides an excellent template for this type of growth strategy. In 1993 a new switching technology emerged that threatened the leadership position that Cisco commanded in network routing. Cisco’s engineering team was confident they could develop their own superior switching product, but it was clear to then CSO Mike Volpi that several well-funded switching companies were already years ahead of Cisco in the race to market. Instead of developing their own product, Cisco decided to acquire an emerging switching company, which turned out to be a huge success. The descendants of that product line provided Cisco with an additional ten billion dollars in revenue.

Continue reading